Pimobendan is used in patients diagnosed with Congestive Heart Failure (CHF). CHF is a condition that results in the inability of the heart to pump required amount of blood throughout the body. Pimobendan increases the force or strength of heart contraction, so that more blood is pumped by the heart and also dilates the blood vessels, which helps the heart receive more blood for pumping as well as blood easily flows out of the heart.

SAFEHEART improves Quality of Life (QoL) and extends Life in patients with CHF due to Dilated Cardiomyopathy (DCM) or Myxomatous Mitral Valve Disease (MMVD). SAFEHEART can also be used to delay onset of CHF & increase survival time in patients with preclinical mitral valve disease and DCM.

Recommended dose:
0.5mg/kg bw per day in two doses, not necessarily equal